Roivant Sciences Ltd. (ROIV) stock forecast and price target
Price $39.53 · data as of November 13, 2026
12-month price target
Average target$50.82
Upside / downside+28.6%
Analysts11
ConsensusStrong buy
Low $42.00Average $50.82High $62.00
Gold marker: average target · white marker: today’s price ($39.53)
Analyst ratings
Strong buy 2Buy 9Hold 2Sell 0Strong sell 0
Earnings and revenue estimates
| Period | EPS estimate | EPS growth | Revenue estimate |
|---|---|---|---|
| Current fiscal year ends March 31, 2027 | $-1.12 | −3.9% | $163M |
| Next fiscal year ends March 31, 2028 | $-1.43 | −27.9% | $605M |
| Quarter after ends March 31, 2027 | $-0.34 | −5.6% | $75M |
Consensus of the analysts covering Roivant Sciences, updated daily. In the last 30 days 0 estimates were raised and 3 lowered.
Frequently asked questions
What is the Roivant Sciences stock price target?
The average 12-month target from 11 analysts is $50.82, 28.6% above the current price of $39.53 Targets range from $42.00 to $62.00.
Is Roivant Sciences a buy according to analysts?
The consensus rating is “Strong buy” (2 strong buy, 9 buy, 2 hold). Ratings are opinions, not guarantees; this is not investment advice.
How much is Roivant Sciences expected to earn?
Analysts expect EPS of $-1.12 for the fiscal year ending March 31, 2027 and $-1.43 the year after.
Analyst consensus estimates and price targets, updated daily. Forecasts can be wrong; this is information, not investment advice.